Insights On Trial Design

1. ePRO's Impact On Patient And Site Journeys 5/15/2024

   Join our solutions experts as they demonstrate how Castor ePRO can enhance your clinical trial by improving the patient experience and streamlining site operations.

2. A Guide To Streamlining Study Start-Up In Australia 9/23/2025

   Discover the benefits of Australia as a premier destination for multinational sponsors looking to expedite drug development, refine trial design, and establish long-term research partnerships.

3. Precision Medicine: Targeted Cancer Therapies 10/2/2025

   Cancer research is entering a new precision-driven era, with targeted therapies focusing on the specific genetic or molecular mechanisms that fuel tumor growth.

4. Overcoming Barriers To Participation 11/22/2024

   Explore effective strategies to enhance diversity and inclusion in clinical trials by supporting underrepresented patient groups, ensuring equitable health outcomes and broader representation.

5. Finding The Solution(s) That Meet The Needs Of Patients, Sites, And Sponsors 12/4/2025

   Poor enrollment and retention often stem from patient burden and limited site access. Learn how leveraging diverse site networks and remote support can transform the clinical trial experience.

6. Innovation Under Pressure: Navigating Clinical Trials Amid a Pandemic 7/23/2024

   How do you complete a Phase 2b rheumatology study in three countries despite global lockdowns? Palleos cracked the code, achieving recruitment targets and regulatory approvals against all odds.

7. Unlocking The Potential of RWD In Clinical Trial Recruitment 4/25/2025

   Insights derived from real-world data can be used not only to identify potential patients for participation in clinical research, but also to inform the overall patient engagement and retention strategy of a clinical trial.

8. Practical Strategies For Diverse Trial Recruitment 11/11/2024

   The clock is ticking on the requirement for pharmaceutical companies to include FDA-mandated diversity action plans for pivotal studies in clinical trials.

9. Digital Physical Activity Measures In Phase 3 Immunology Trials 2/25/2025

   Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.

10. How Mobile Research Nursing Is Improving Rare Disease Clinical Trials 9/5/2024

    Learn how home visits enhance the patient experience in rare disease studies and how sponsors can use mobile research nurses to reach more rare disease patients and keep them in clinical trials longer.